Healthgen’s “Recombinant Human Albumin Injection(Oryza Sativa)” was approved by the China’s National Medical Products Administration (NMPA)on 18 July, 2025.
Drug Name: Recombinant Human Albumin Injection (Oryza Sativa)
Drug Approval No.: National Drug Approval No.S20250039
Indications: Hypoproteinemia
Packing: 10g(20%,50mL)